GSK recalls Paxil after FDA issues warning letter
GlaxoSmithKline has said it will recall some batches of its antidepressants Paxil and Seroxat because the active ingredient used to make them might have been tainted. But the U.K.-based drugmaker didn't decide to take the step until it was publicly chastised by the FDA about the problem in a warning letter.
Read more: News - FiercePharma Manufacturing http://www.fiercepharmamanufacturing.com/news#ixzz2yUrEnWe8
Subscribe at FiercePharma Manufacturing
No comments:
Post a Comment